Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, Large B-Cell, Diffuse 11 Lung Neoplasms 10 Burkitt Lymphoma 9 Leukemia, Myeloid, Acute 8 Lymphoma 7 Hodgkin Disease 6 Carcinoma, Non-Small-Cell Lung 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms 5 Multiple Myeloma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, B-Cell 5 Sarcoma, Ewing 3 Sarcoma 3 Rhabdomyosarcoma 3 Rhabdoid Tumor 3 Retinoblastoma 3 Recurrence 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Neuroblastoma 3 Neoplasms, Germ Cell and Embryonal 3 Myelodysplastic Syndromes 3 Medulloblastoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Follicular 3 Leukemia 3 Immunoblastic Lymphadenopathy 3 Seminoma 2

Interventions

avelumab 7 Nivolumab 5 pembrolizumab 4 Specimen Handling 3 Ipilimumab 3 Biopsy 3 cemiplimab 2 atezolizumab 2 Radiotherapy 2 Magnetic Resonance Spectroscopy 2 tocilizumab 1 talimogene laherparepvec 1 prednylidene 1 poly ICLC 1 lutetium Lu 177 dotatate 1 lenvatinib 1 fludarabine phosphate 1 fludarabine 1 flt3 ligand protein 1 durvalumab 1 deltacortene 1 Tacrolimus 1 Saline Solution 1 Radiosurgery 1 Radiation 1 Prednisone 1 MAPRE1 protein, human 1 Lutetium-177 1 Immunoglobulin G 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Carcinoma, Merkel Cell × Etoposide × Clear all

NCT05594290 2026-01-14

MERCURY

Gruppo Oncologico del Nord-Ovest

Phase 2 Active not recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡